Edition:
United Kingdom

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

41.23USD
25 Sep 2018
Change (% chg)

$0.56 (+1.38%)
Prev Close
$40.67
Open
$40.81
Day's High
$41.47
Day's Low
$40.76
Volume
636,762
Avg. Vol
676,680
52-wk High
$45.09
52-wk Low
$35.10

Chart for

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 0.94
Market Cap(Mil.): $10,571.04
Shares Outstanding(Mil.): 280.47
Dividend: --
Yield (%): --

Financials

  HOLX.OQ Industry Sector
P/E (TTM): 14.07 148.68 32.76
EPS (TTM): 2.68 -- --
ROI: 12.04 9.38 14.61
ROE: 31.17 14.71 16.33

BRIEF-Hologic Receives Health Canada Authorization To Market Sculpsure Laser

* HOLOGIC RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET SCULPSURE® LASER FOR NON-INVASIVE BODY CONTOURING (LIPOLYSIS) OF THE BACK, INNER AND OUTER THIGHS, AND UNDER THE CHIN Source text for Eikon: Further company coverage:

03 May 2018

BRIEF-Hologic Q2 GAAP Loss Per Share $2.46

* HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL 2018

02 May 2018

BRIEF-FDA Approval Of Thinprep Integrated Imager Expands Automated Imaging For Pap Testing To More Labs

* FDA APPROVAL OF THINPREP® INTEGRATED IMAGER EXPANDS AUTOMATED IMAGING FOR PAP TESTING TO MORE LABS

25 Apr 2018

BRIEF-Enzo Biochem Says Patent Trial And Appeal Board Has Denied A Petition Filed By Hologic For Inter Partes Review

* ENZO BIOCHEM INC - PATENT TRIAL AND APPEAL BOARD HAS DENIED A PETITION FILED BY HOLOGIC FOR INTER PARTES REVIEW Source text for Eikon: Further company coverage:

24 Apr 2018

BRIEF-FDA Approves New Innovations On Hologic's 3Dimensions™ Mammography System

* FDA APPROVES NEW INNOVATIONS ON HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM, THE FASTEST, HIGHEST RESOLUTION BREAST TOMOSYNTHESIS SYSTEM EVER(1)

27 Mar 2018

Competitors

Earnings vs. Estimates